Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma.

Blood·2024
Same author

Development of Plasmodium falciparum liver-stages in hepatocytes derived from human fetal liver organoid cultures.

Nature communications·2023
Same author

Uncovering the mode of action of engineered T cells in patient cancer organoids.

Nature biotechnology·2022
Same author

Author Correction: Establishment of patient-derived cancer organoids for drug-screening applications.

Nature protocols·2021
Same author

Single-cell derived tumor organoids display diversity in HLA class I peptide presentation.

Nature communications·2020
Same author

Establishment of patient-derived cancer organoids for drug-screening applications.

Nature protocols·2020

Related Experiment Video

Updated: Dec 5, 2025

Establishment and Culture of Patient-Derived Breast Organoids
08:29

Establishment and Culture of Patient-Derived Breast Organoids

Published on: February 17, 2023

5.7K

Cancer research using organoid technology.

Kai Kretzschmar1

  • 1Mildred Scheel Early Career Centre (MSNZ) for Cancer Research Würzburg, University Hospital Würzburg, MSNZ/IZKF, Josef-Schneider-Str. 2, 97080, Würzburg, Germany. kai.kretzschmar@uni-wuerzburg.de.

Journal of Molecular Medicine (Berlin, Germany)
|October 15, 2020
PubMed
Summary
This summary is machine-generated.

Organoid technology revolutionizes cancer research by enabling the study of tumor initiation, progression, and drug screening. Further development is needed for its widespread use in anti-cancer therapy.

Keywords:
3D cultureCancerDrug screeningImmuno-oncologyOrganoidsPersonalised medicinePre-clinical models

More Related Videos

Generating and Imaging Mouse and Human Epithelial Organoids from Normal and Tumor Mammary Tissue Without Passaging
08:57

Generating and Imaging Mouse and Human Epithelial Organoids from Normal and Tumor Mammary Tissue Without Passaging

Published on: November 11, 2022

3.2K
Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer
08:54

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Published on: June 13, 2019

11.2K

Related Experiment Videos

Last Updated: Dec 5, 2025

Establishment and Culture of Patient-Derived Breast Organoids
08:29

Establishment and Culture of Patient-Derived Breast Organoids

Published on: February 17, 2023

5.7K
Generating and Imaging Mouse and Human Epithelial Organoids from Normal and Tumor Mammary Tissue Without Passaging
08:57

Generating and Imaging Mouse and Human Epithelial Organoids from Normal and Tumor Mammary Tissue Without Passaging

Published on: November 11, 2022

3.2K
Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer
08:54

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer

Published on: June 13, 2019

11.2K

Area of Science:

  • Biomedical Research
  • Cancer Biology
  • Organoid Technology

Background:

  • Organoid technology has significantly advanced biomedical research over the past decade.
  • Cancer organoid cultures offer new avenues for cancer research and therapeutic strategies.
  • These organoids are derived from both healthy and cancerous tissues.

Purpose of the Study:

  • To review the current applications of organoid technology in cancer research.
  • To discuss the potential of organoids in anti-cancer therapy.
  • To identify challenges hindering the broader clinical use of organoids.

Main Methods:

  • Utilizing organoid cultures derived from healthy tissues to study tumor initiation and progression.
  • Employing cancer organoid cultures for biobanking, drug screening, and mutational signature analysis.
  • Incorporating tumor microenvironment components, including immune cells, into organoid cultures for immuno-oncology research.

Main Results:

  • Organoids are instrumental in studying various aspects of tumor development, including the roles of pathogens and cancer genes.
  • Cancer organoids serve as valuable tools for drug screening and understanding mutational patterns.
  • The integration of tumor microenvironment elements enhances organoid utility in immuno-oncology.

Conclusions:

  • Organoid technology is a powerful tool in current cancer research, offering insights into tumor biology and treatment responses.
  • Further research and overcoming existing obstacles are crucial for the broader clinical application of organoid technology in anti-cancer therapy.